Francesco Cognetti

1.1k total citations
38 papers, 589 citations indexed

About

Francesco Cognetti is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Francesco Cognetti has authored 38 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 15 papers in Molecular Biology and 10 papers in Cancer Research. Recurrent topics in Francesco Cognetti's work include Pancreatic and Hepatic Oncology Research (8 papers), Breast Cancer Treatment Studies (7 papers) and Melanoma and MAPK Pathways (6 papers). Francesco Cognetti is often cited by papers focused on Pancreatic and Hepatic Oncology Research (8 papers), Breast Cancer Treatment Studies (7 papers) and Melanoma and MAPK Pathways (6 papers). Francesco Cognetti collaborates with scholars based in Italy, Malaysia and United States. Francesco Cognetti's co-authors include Fabiana Conciatori, Italia Falcone, Chiara Bazzichetto, G. Ferretti, Michèle Milella, Ludovica Ciuffreda, Maria Simona Pino, Vincenzo Mollace, Saverio Nucera and Vincenzo Musolino and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Francesco Cognetti

37 papers receiving 586 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francesco Cognetti Italy 12 288 198 106 105 95 38 589
Yiqing Xu United States 15 393 1.4× 393 2.0× 176 1.7× 102 1.0× 99 1.0× 48 891
Kyoung Mee Kim South Korea 16 215 0.7× 202 1.0× 179 1.7× 74 0.7× 181 1.9× 40 653
Zacharias Fasoulakis Greece 14 169 0.6× 386 1.9× 93 0.9× 202 1.9× 72 0.8× 73 824
Yoshiaki Okuno Japan 20 248 0.9× 231 1.2× 78 0.7× 80 0.8× 57 0.6× 41 796
Alexandra Colquhoun United Kingdom 12 194 0.7× 272 1.4× 149 1.4× 125 1.2× 119 1.3× 28 677
Pranay Tanwar India 15 184 0.6× 245 1.2× 86 0.8× 122 1.2× 61 0.6× 80 658
Hossam Kamel Egypt 3 219 0.8× 169 0.9× 69 0.7× 120 1.1× 89 0.9× 11 631
Dan Pu China 14 182 0.6× 174 0.9× 91 0.9× 81 0.8× 88 0.9× 54 602
Parul Gupta India 11 185 0.6× 260 1.3× 91 0.9× 65 0.6× 42 0.4× 41 582

Countries citing papers authored by Francesco Cognetti

Since Specialization
Citations

This map shows the geographic impact of Francesco Cognetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesco Cognetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesco Cognetti more than expected).

Fields of papers citing papers by Francesco Cognetti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesco Cognetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesco Cognetti. The network helps show where Francesco Cognetti may publish in the future.

Co-authorship network of co-authors of Francesco Cognetti

This figure shows the co-authorship network connecting the top 25 collaborators of Francesco Cognetti. A scholar is included among the top collaborators of Francesco Cognetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesco Cognetti. Francesco Cognetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Fabi, Alessandra, Matteo Allegretti, G. Ferretti, et al.. (2023). Abstract OT1-22-01: Liquid biopsy and Ado-trastuzumab emtansine (T-DM1): drug-resistance traits in the blood of HER2-positive metastatic breast cancer patients. Cancer Research. 83(5_Supplement). OT1–22. 1 indexed citations
3.
Botticelli, Andrea, Simone Scagnoli, Pierfranco Conté, et al.. (2023). Abstract P6-10-09: Mutational landscape of breast cancer patients in ROME trial: preliminary results. Cancer Research. 83(5_Supplement). P6–10. 1 indexed citations
4.
Annovazzi, Alessio, et al.. (2022). Palbociclib plus letrozole induces a complete metabolic response in metastatic breast cancer patient with idiopathic thrombocytopenia. Recenti Progressi in Medicina. 113(6). 376–379. 1 indexed citations
5.
Cognetti, Francesco & Giuseppe Naso. (2021). The clinician’s perspective on the 21-gene assay in early breast cancer. Oncotarget. 12(26). 2514–2530. 2 indexed citations
6.
Mastro, Lucia Del, Mauro Mansutti, Giancarlo Bisagni, et al.. (2021). 118O Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: A randomised, phase III trial of the Gruppo Italiano Mammella. Annals of Oncology. 32. S407–S408. 1 indexed citations
7.
Noia, Vincenzo Di, et al.. (2021). The first report on coronavirus disease 2019 (COVID-19) vaccine refusal by patients with solid cancer in Italy: Early data from a single-institute survey. European Journal of Cancer. 153. 260–264. 33 indexed citations
8.
Vari, Sabrina, Alessio Annovazzi, Vincenzo Anelli, et al.. (2021). Case Report: Rechallenge With BRAF and MEK Inhibitors in Metastatic Melanoma: A Further Therapeutic Option in Salvage Setting?. Frontiers in Oncology. 11. 645008–645008. 4 indexed citations
9.
Falcone, Italia, Fabiana Conciatori, Chiara Bazzichetto, et al.. (2020). AXL Receptor in Breast Cancer: Molecular Involvement and Therapeutic Limitations. International Journal of Molecular Sciences. 21(22). 8419–8419. 20 indexed citations
10.
Bazzichetto, Chiara, Claudio Luchini, Fabiana Conciatori, et al.. (2020). Morphologic and Molecular Landscape of Pancreatic Cancer Variants as the Basis of New Therapeutic Strategies for Precision Oncology. International Journal of Molecular Sciences. 21(22). 8841–8841. 33 indexed citations
11.
Bazzichetto, Chiara, Fabiana Conciatori, Claudio Luchini, et al.. (2020). From Genetic Alterations to Tumor Microenvironment: The Ariadne’s String in Pancreatic Cancer. Cells. 9(2). 309–309. 25 indexed citations
12.
Mormando, Marilda, Giulia Puliani, Agnese Barnabei, et al.. (2020). A Rare Case of Pituitary Melanoma Metastasis: A Dramatic and Prolonged Response to Dabrafenib-Trametinib Therapy. Frontiers in Endocrinology. 11. 471–471. 6 indexed citations
13.
Falcone, Italia, Fabiana Conciatori, Chiara Bazzichetto, et al.. (2020). Tumor Microenvironment: Implications in Melanoma Resistance to Targeted Therapy and Immunotherapy. Cancers. 12(10). 2870–2870. 91 indexed citations
14.
Fabi, Alessandra, Marcella Mottolese, Anna Di Benedetto, et al.. (2020). p53 and BLC2 Immunohistochemical Expression Across Molecular Subtypes in 1099 Early Breast Cancer Patients With Long-Term Follow-up: An Observational Study. Clinical Breast Cancer. 20(6). e761–e770. 5 indexed citations
15.
Conciatori, Fabiana, Chiara Bazzichetto, Italia Falcone, et al.. (2019). Colorectal cancer stem cells properties and features: evidence of interleukin-8 involvement. Cancer Drug Resistance. 2(4). 968–979. 11 indexed citations
16.
Bazzichetto, Chiara, et al.. (2017). Tumor-stroma interactions and response to targeted agents in preclinical models of colorectal cancer (CRC). Annals of Oncology. 28. v169–v169. 1 indexed citations
17.
Bidoli, Paolo, Rita Chiari, Annamaria Catino, et al.. (2016). Efficacy and safety data from patients with advanced squamous NSCLC and brain metastases participating in the nivolumab Expanded Access Programme (EAP) in Italy. Annals of Oncology. 27. vi425–vi425. 18 indexed citations
18.
Vaccaro, Vanja, Emilio Bria, Isabella Sperduti, et al.. (2012). Optimizing supportive measures for the safe administration of FOLFIRINOX as first-line treatment in advanced, inoperable pancreatic cancer (aPDAC) patients (pts) in routine clinical practice.. Journal of Clinical Oncology. 30(15_suppl). e14661–e14661. 2 indexed citations
19.
Ricciardi, Maria Rosaria, Ludovica Ciuffreda, Sabina Chiaretti, et al.. (2005). Effective Targeting of MEK/ERK Signalling at Nanomolar Concentrations by the Novel Small Molecule Inhibitor PD0325901 in Hematopoietic and Solid Tumors.. Blood. 106(11). 3370–3370. 1 indexed citations
20.
Gelibter, Alain, Serena Di Cosimo, Enzo Maria Ruggeri, et al.. (2004). Fixed dose-rate gemcitabine (GEM) infusion in advanced pancreatic (PDAC) and biliary tree (BTC) carcinoma: A phase II study. Journal of Clinical Oncology. 22(14_suppl). 4182–4182. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yiqing Xu Breakdown of academic impact, for papers by Kyoung Mee Kim Breakdown of academic impact, for papers by Zacharias Fasoulakis Breakdown of academic impact, for papers by Yoshiaki Okuno Breakdown of academic impact, for papers by Alexandra Colquhoun Breakdown of academic impact, for papers by Pranay Tanwar Breakdown of academic impact, for papers by Hossam Kamel Breakdown of academic impact, for papers by Dan Pu Breakdown of academic impact, for papers by Parul Gupta
Rankless by CCL
2026